The results revealed that the strength of most signaling pathways was markedly enhanced in the high ERS risk subpopulation, including CHAD, NOTCH, FN1, SPP1, VEGF, etc. This evidence concerns the gene VEGFA and amelogenesis imperfecta type 1G.